{"url":"https://lda.senate.gov/api/v1/filings/8ef77455-e42f-49c9-acf2-820eac2aed0a/","filing_uuid":"8ef77455-e42f-49c9-acf2-820eac2aed0a","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2025,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/8ef77455-e42f-49c9-acf2-820eac2aed0a/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Noe Garcia III","dt_posted":"2026-01-20T09:58:11-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1010 Wisconsin Avenue NW","registrant_address_2":"Suite 710","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20007","registrant":{"id":401105597,"url":"https://lda.senate.gov/api/v1/registrants/401105597/","house_registrant_id":null,"name":"FORWARD GLOBAL","description":"Government Affairs and Consulting","address_1":"1010 Wisconsin Avenue NW","address_2":"Suite 710","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20007","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NOE GARCIA","contact_telephone":"+1 202-870-8298","dt_updated":"2026-01-30T16:54:17.259897-05:00"},"client":{"id":66065,"url":"https://lda.senate.gov/api/v1/clients/66065/","client_id":66065,"name":"QUOIN PHARMACEUTICALS, INC.","general_description":"Development and commercialization of therapeutic drug products that treat rare diseases.","client_government_entity":null,"client_self_select":false,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-02-24"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Lobbying for continued funding from the government for rare disease research and development, including through the Rare Pediatric Disease Designation and Priority Review Voucher Programs; advocating for greater awareness about the rare disease community for doctors via the Give Kids a Chance Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":99335,"prefix":null,"prefix_display":null,"first_name":"NOE","nickname":null,"middle_name":null,"last_name":"GARCIA","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":148495,"prefix":null,"prefix_display":null,"first_name":"AVA","nickname":null,"middle_name":null,"last_name":"COFIELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106704,"prefix":null,"prefix_display":null,"first_name":"LEAH","nickname":null,"middle_name":null,"last_name":"CHARETTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Lobbying for continued funding from the government for rare disease research and development, including through the Rare Pediatric Disease Designation and Priority Review Voucher Programs; advocating for greater awareness about the rare disease community for doctors via the Give Kids a Chance Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":99335,"prefix":null,"prefix_display":null,"first_name":"NOE","nickname":null,"middle_name":null,"last_name":"GARCIA","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":148495,"prefix":null,"prefix_display":null,"first_name":"AVA","nickname":null,"middle_name":null,"last_name":"COFIELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106704,"prefix":null,"prefix_display":null,"first_name":"LEAH","nickname":null,"middle_name":null,"last_name":"CHARETTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Lobbying for continued funding from the government for rare disease research and development, including through the Rare Pediatric Disease Designation and Priority Review Voucher Programs; advocating for greater awareness about the rare disease community for doctors via the Give Kids a Chance Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":99335,"prefix":null,"prefix_display":null,"first_name":"NOE","nickname":null,"middle_name":null,"last_name":"GARCIA","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":148495,"prefix":null,"prefix_display":null,"first_name":"AVA","nickname":null,"middle_name":null,"last_name":"COFIELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106704,"prefix":null,"prefix_display":null,"first_name":"LEAH","nickname":null,"middle_name":null,"last_name":"CHARETTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}